智慧財產權月刊 219期

8 /88

8
本月專題
專利權期間延長審查實務之探討與建議
106.03 智慧財產權月刊 VOL.219
௄՟ה੻ʘ௰ ڋ஢̙dՉܝᚃ০࿁ʔΝኒۨeʔΝԴ͜ኒඎeʔΝఊЗўඎഃ՟
੻ʘ஢̙dѩ ᙮ڢୋɓϣ஢̙ᗇf
০࿁Ң਷༈ୋɓϣ஢̙ᗇႩ֛ᅺ๟d̮ޢ ϞʔΝจԈdႩ ༈މᅺ๟Ч˷ཀ׵
ᘌ߭fˈՉd˚͉ 2015 ϋ௰৷৫ج Gyo-Hi No.356 кӔ 1 ʿ׵ 2016 ϋ ࠈࡌʮѓ
ٙਖ਼лᛆಂගַ ڗਿ๟ʊਗ਼ୋɓϣ஢̙ᗇႩ֛ᅺ๟ɽష׳ᄱd݂ҷഛ˙ࣩʃଡ଼ਗ਼
༈ᙄᕚ౤̈ীሞԨ޼ᏝЪϓ࿁׵ୋɓϣᖹۜ஢̙ᗇʘႩ֛ᅺ๟ʘࣩ͠ - Ϟࣖϓʱe
͜௄eኒۨeኒඎdɔࣩķϞࣖϓʱe͜௄eኒۨfઓϞᗫୋɓϣᖹۜ஢̙ᗇႩ
֛ᅺ๟d׵˜ܠϽࡌ͍ୋɓϣᖹۜ஢̙ᗇʘႩ֛ᅺ๟ʿࣨࡘַ ೯ڗ׼ਖ਼лᛆಂග
ʘᇍఖ™ɓ˖ 2 ʕdϞ༉୚ઞীf
二、選定第一次藥品許可證
ਖ਼лᛆಂගַڗ͡ሗɛ౤Զɚੵ˸ɪ஢̙ᗇʘ͡ሗd༈஢̙ᗇা༱޴ΝϞࣖ
ϓʱʿᔼᖹ͜௄dઓ̍ўা༱ʔΝʘԴ͜ኒඎeኒۨഃfԷνה ৔ɚੵ஢̙ᗇ˴
ࠅϞࣖϓʱޫމ˜Secukinumab™dᔼᖹ͜௄ቇᏐसޫމ˜౴෯׌৻ᛎjط ᐕቇΥ
ટաΌԒ׌طᐕٙʕЇࠠܓ ౴෯׌৻ᛎϓɛઃ٫f৻ᛎ׌ᗫືفjطᐕઃϞݺ ਗ
׌৻ᛎ׌ᗫືفٙϓɛषɛf̙ఊዹԴ͜אၾ methotrexate Ի͜fᄅٜ׌঑ಖفj
ط ᐕݺਗ׌ᄅٜ׌঑ಖفϓɛषઃ™dШኒۨމۆʔΝdɓމ˜27D ء࢛૰ኒ™d
̤ɓ މ˜247 ౺ࡖ৻४ء࢛ኒ™dϤ၇ઋҖɨd͡ሗɛ඲΋኿֛ɓੵ஢̙ᗇd˲ה
኿Ꮠၾڝה ਷lze̮ᑗґ༊᜕הԴ͜ኒඎeኒۨഃɓ٫ߧdމୋɓϣᖹۜ஢̙ᗇf
މе͡ሗɛ࿁׵ਿ๟ʘ˖οϞ הႬ༆dҷഛ˙ࣩʃଡ଼ܔᙄd׵ਿ๟˜ਖ਼лᛆ
ಂගַڗՓ ܓʘͭجͦٙڷ ໾ԑᔼᖹۜe༵ᖹۜʿՉႡ೯ج׼ਖ਼л඲຾ج ֛ᄲݟ
՟੻ɪ̹஢̙ᗇdϾೌجྼ݄೯׼ਖ਼лʘಂගd݂ɓ΁೯׼ਖ਼лࣩdਖ਼лᛆɛ੻
͡ሗַ ڗʘϣᅰසࠢɓϣ™3 ʘ˖οʕᄣΐ˜˲ස੻ఱɓੵ஢̙ᗇ͡ሗַڗ™ʘ
ાࠑd˸૶ู༺ڌਖ਼лᛆಂගַڗ͡ሗdසࠢԴ͜ɓੵୋɓϣᖹۜ஢̙ᗇd˲ස
ঐఱɓࣩ͡ሗַڗɓϣf
1 The Supreme Court of Japan (SCJ) rendered a decision (SCJ decision No. 2014 (Gyo-Hi) 356) on
November 17, 2015, to dismiss the final appeal by the Japan Patent Office (JPO) against the decisions
held by the Intellectual Property High Court of Japan (IPHC) for registration of patent term extension
(PTE).
2 ੵɿ۾ dܠϽࡌ ͍ୋɓϣᖹۜ஢̙ᗇʘႩ֛ᅺ๟ʿࣨࡘ ַ೯ڗ׼ਖ਼лᛆಂගʘᇍఖ{ఱҢ਷Ⴁ
ᖹุอኒۨᖹي ޼೯ঐඎϾሞd౽ᅆৌପᛆ˜̊ 219 ಂf
3 ୋɚᇐ೯׼ਖ਼лྼ᜗ᄲݟ ਿ๟ୋɤɓ௝ਖ਼лᛆಂගַڗ 2.5 ͡ሗਖ਼лᛆಂගַڗ ʘϣᅰf